| Literature DB >> 32148660 |
Yuen-Shan Ho1, Fei-Yi Zhao2, Wing-Fai Yeung1, Gordon Tin-Chun Wong3, Hong-Qi Zhang4, Raymond Chuen-Chung Chang5,6.
Abstract
Postoperative cognitive dysfunction (POCD) is a common sequela following surgery and hospitalization. The prevention and management of POCD are important during clinical practice. POCD more commonly affects elderly patients who have undergone major surgery and can result in major decline in quality of life for both patients and their families. Acupuncture has been suggested as an effective intervention for many neurological disorders. In recent years, there are increasing interest in the use of acupuncture to prevent and treat POCD. In this review, we summarized the clinical and preclinical evidence of acupuncture on POCD using a narrative approach and discussed the potential mechanisms involved. The experimental details and findings of studies were summarized in tables and analyzed. Most of the clinical studies suggested that acupuncture before surgery could reduce the incidence of POCD and reduce the levels of systematic inflammatory markers. However, their reliability is limited by methodological flaws. Animal studies showed that acupuncture reduced cognitive impairment and the associated pathology after various types of surgery. It is possible that acupuncture modulates inflammation, oxidative stress, synaptic changes, and other cellular events to mitigate POCD. In conclusion, acupuncture is a potential intervention for POCD. More clinical studies with good research design are required to confirm its effectiveness. At the same time, findings from animal studies will help reveal the protective mechanisms, in which systematic inflammation is likely to play a major role.Entities:
Year: 2020 PMID: 32148660 PMCID: PMC7044481 DOI: 10.1155/2020/9641904
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Summary of clinical trials examining the effects of acupuncture on POCD.
| Author/year | Types of surgery | Study groups/no. of participants | Acupuncture intervention | Acupoints | Outcome measures | Results (compared with the control group) |
|---|---|---|---|---|---|---|
| Yang et al./2009 [ | Coronary artery bypass grafting or cardiac valve replacement surgery | (i) Control: usual care/ | EA, 5 days before surgery, 30 min/day | LU2, LU7, PC6 | MMSE, digit span subtest, digit symbol subtest, trail making test, short story memory test | (i) No differences in POCD incidence rates at postoperative days 7 and 14 between the two groups |
|
| ||||||
| Zhou et al./2011 [ | Off-pump coronary artery bypass grafting | (i) Control: usual care+sham EA/ | EA, 30 min before surgery to the end of surgery | PC6 | MMSE | (i) No differences in POCD incidence rates at the postoperative time points of 1 week and 1 month between the two groups |
|
| ||||||
| Zhang et al./2012 [ | Hip or knee replacement surgery | (i) Control: usual care/ | EA, 30 min before surgery | DU20, DU24 | MMSE, serum S100 | (i) Lower POCD incidence rate at postoperative day 1 in the intervention group |
|
| ||||||
| Gao et al./2012 [ | Noncardiac surgery | (i) Control: usual care/ | EA, 30 min before surgery to the end of surgery | DU20, PC6, ST36, LI4 | MMSE, PONV incidence | (i) Incidence rates of POCD were lower at postoperative days 2 and 4 in the intervention group |
|
| ||||||
| Lin et al./2013a [ | Intestinal cancer resection | (i) Control: usual care/ | EA/TENS, 30 min before surgery to the end of surgery | DU20, EX-HN3, PC6 | MMSE, serum S100 | (i) Lower POCD incidence rate at postoperative day 3 in the EA and TENS group |
|
| ||||||
| Lin et al./2013b [ | Intestinal cancer resection | (i) Control: usual care/ | EA, 20 min before surgery to the end of surgery | DU20, PC6, SP6, ST36 | MMSE, serum S100 | (i) Lower POCD incidence rate at postoperative day 3 in the intervention group |
|
| ||||||
| Lin et al./2014 [ | Gastrointestinal cancer resection | (i) Control: usual care/ | EA, 30 min before surgery to the end of surgery | DU20, PC6, ST36 | MMSE, serum IL-1 | (i) Lower POCD incidence rate at postoperative day 3 in the intervention group |
|
| ||||||
| Wang et al./2014 [ | Hip replacement surgery | (i) Control: usual care/ | EA, 1 day before and 1 day after surgery, once daily, 30 min | Scalp acupuncture lines MS1, MS5, 2/5 middle of MS7, MS10 | Neuropsychological test (did not mention the details) | (i) Lower POCD incidence rates at the postoperative time points of 6 days, 1 week, 3 months, and 6 months in the intervention group |
|
| ||||||
| Zhang et al./2014 [ | Abdominal surgery | (i) Control: usual care/ | EA, 30 min before surgery to the end of surgery | DU20, DU24, PC6 | MMSE, PONV incidence | (i) Lower POCD and PONV incidence rates at the postoperative time point of 48 h in the intervention group |
|
| ||||||
| Zhang et al./2014 [ | Knee replacement surgery | (i) Control: usual care/ | EA, 30 min before surgery | DU20, DU24 | MMSE, serum IL-1 | (i) Lower POCD incidence rate at postoperative day 1 in the intervention group |
|
| ||||||
| Zhou et al./2014 [ | Lumbar spinal stenosis surgery | (i) Control: usual care/ | EA, 30 min before surgery to the end of surgery | LI4, PC6, SP6, ST36 | MMSE, serum IL-6, IL-10, S100 | (i) Lower POCD incidence rate at the postoperative time point of 72 h in the intervention group |
|
| ||||||
| Chen/2015 [ | Gynecological laparoscopic surgery | (i) Control: usual care/ | EA, 30 min before and 30 min after surgery | LI4, PC6 | MMSE, QoR-40, serum IL-6, | (i) Higher MMSE scores and lower PONV incidence at postoperative day 2 in the intervention group |
|
| ||||||
| Chen/2015 [ | Laparoscopic cholecystectomy | (i) Control: usual care/ | EA, 15-30 min before surgery to the end of surgery | GB34, LI4, PC6, ST36 | MMSE, serum S100 | (i) Lower POCD incidence rate at postoperative day 3 in the intervention group |
|
| ||||||
| Jiang et al./2015 [ | Hip or knee replacement surgery | (i) Control: usual care/ | EA, 5 days before surgery, 30 min/day | DU14, DU20 | MMSE | (i) Lower POCD incidence rate at postoperative day 1 in the intervention group |
|
| ||||||
| Jiang/2015 [ | Coronary artery bypass grafting | (i) Control: usual care+sham EA/ | EA, 30 min before surgery to the end of surgery | PC6 | MMSE, serum S100 | (i) Lower POCD incidence rate at postoperative day 3 in the intervention group |
|
| ||||||
| Qing and Jiang/2015 [ | Surgery for brain trauma | (i) Control: usual care/ | MA (scalp acupuncture) after surgery, 30 min/day for 24 days | DU17, DU24, GB13, GB19, and other scalp acupoints | MMSE | (i) Higher MMSE scores at postoperative day 24 in the treatment group |
|
| ||||||
| Yang et al./2015 [ | Gastrointestinal cancer resection | (i) Normal: patients without diabetes/ | EA, 20 min before surgery to the end of surgery | DU20, LI10, LI11, PC6 | MMSE, serum IL-1 | (i) Lower POCD incidence rate at postoperative day 3 in the intervention group |
|
| ||||||
| Zhang et al./2015 [ | Laparoscopic cholecystectomy | (i) Control: usual care+sham EA/ | EA after surgery, 20 min/day for 7 days | DU20, PC6 | MMSE | (i) Lower POCD incidence rate at postoperative days 1 and 3 in the intervention group |
|
| ||||||
| Dong et al./2016 [ | Intestinal cancer resection | (i) Control: usual care/ | EA, 30 min before surgery to the end of surgery | DU20, PC6 | MMSE, PONV incidence | (i) Lower POCD incidence rates at postoperative days 1 and 3 in the intervention group |
|
| ||||||
| Xie et al./2016 [ | Hip replacement surgery | (i) Control: usual care/ | EA, 30 min before the end of surgery+after surgery, daily for 2 days, 30 min | DU24, GB13 | PQRS | (i) Lower POCD incidence rates at postoperative days 1, 2, 3, and 5 in the intervention group |
|
| ||||||
| Yu et al./2016 [ | Intestinal cancer resection | (i) Control: usual care/ | EA during surgery | DU20, PC6, SP6, ST36 | MMSE | (i) Lower POCD incidence rate at the postoperative time points of 6 and 12 h in the intervention group |
|
| ||||||
| Yuan et al./2016 [ | Extracerebral intervention | (i) Control: usual care/ | EA, 30 min before surgery | DU20, PC6, EX-HN3 | MMSE, serum IL-1 | (i) Lower POCD incidence rate at postoperative day 1 in the intervention group |
|
| ||||||
| Lin et al./2016 [ | Carotid endarterectomy | (i) Control: usual care/ | EA, 30 min before surgery to the end of surgery | DU20, PC6, ST36 | MoCA, plasma TNF- | (i) Higher MoCA scores at postoperative days 1, 3, and 7 in the intervention group |
|
| ||||||
| Li/2017 [ | Various types | (i) Control: usual care/ | EA, 30 min before surgery to the end of surgery | DU20, PC6, ST36 | Serum TNF- | (i) Lower postoperative serum IL-1 |
|
| ||||||
| Li et al./2016 [ | Hip replacement surgery | (i) Control: usual care/ | EA during surgery | MS1, MS5 | Neuropsychological test, serum S100 | (i) Lower POCD incidence rates at the postoperative time points of 3 days, 1 week, 3 months, and 6 months in the intervention group |
|
| ||||||
| Liu et al./2017 [ | Hip replacement surgery | (i) Control: usual care/ | EA, 3 days before and 3 days after surgery, once daily, 30 min+30 min before surgery to the end of surgery | LI4, LR3 | MMSE, serum IL-1 | (i) Lower POCD incidence rate at postoperative day 4 in the intervention group |
|
| ||||||
| Liu and Teng/2017 [ | Tumor resection | (i) Control: usual care/ | EA, 30 min before surgery to the end of surgery | DU20, PC6, ST36 | MMSE, serum IL-1 | (i) Lower POCD incidence rates at postoperative days 1 and 3 in the intervention group |
|
| ||||||
| Tao et al./2017 [ | Knee replacement surgery | (i) Control: usual care/ | EA during surgery | DU20, DU24, PC6 | MMSE | (i) Lower POCD incidence rate at postoperative day 1 in the intervention group |
|
| ||||||
| Wang/2017 [ | Nonspecific type | (i) Control: usual care/ | EA, after surgery, once daily for 7 days, 30 min | DU20, PC6 | MMSE, FAQ | (i) Higher MMSE and lower FAQ scores at postoperative days 1 and 3 in the intervention group |
|
| ||||||
| Xiao et al./2017 [ | Cardiac valve replacement with cardiopulmonary bypass | (i) Control: usual care/ | EA, 20 min before surgery to the end of surgery | DU20, HT7, PC4, PC6 | MMSE, PONV incidence | (i) Lower POCD incidence rate at postoperative day 3 in the intervention group |
|
| ||||||
| Zhang et al./2017 [ | Cardiac valve replacement with cardiopulmonary bypass | (i) Control: usual care+sham EA/ | (i) EA, 20 min before surgery to the end of surgery | DU20, DU24, PC4, PC6 | MMSE, QOR-9, PONV incidence | (i) Higher MMSE scores at postoperative days 1 and 3 in the intervention group |
|
| ||||||
| Zhang et al./2017 [ | Spine surgery | (i) Control: usual care/ | EA, 30 min before surgery to the end of surgery | DU14, DU20, ST36 | MMSE, serum IL-6, IL-10, S100 | (i) Higher MMSE scores at postoperative day 7 in the intervention group |
|
| ||||||
| Zhao and Li/2017 [ | Laparoscopic cholecystectomy | (i) Control: usual care/ | MA or EA after surgery, 30 min/day for 7 days | DU20, PC6 | MMSE, FAQ | (i) Higher MMSE scores at postoperative days 1 and 3 in the EA and MA groups |
|
| ||||||
| Zheng/2017 [ | Intestinal cancer resection | (i) Control: usual care/ | EA during surgery | DU20, PC6, SP6, ST36 | MMSE | (i) Lower POCD incidence rates at the postoperative time points of 6 and 12 h in the intervention group |
|
| ||||||
| Dong et al./2018 [ | Hip replacement surgery | (i) Control: usual care/ | MA, 20 min before surgery | DU20, LI4, PC6, ST36 | MMSE | (i) Lower POCD incidence rate at postoperative day 1 in both intervention groups |
|
| ||||||
| Han/2018 [ | Intestinal cancer resection | (i) Control: usual care/ | EA SW 20 min before surgery to the end of surgery | DU20, PC6, SP6, ST36 | MMSE, serum S100 | (i) Higher MMSE scores at the postoperative time points of 12, 24, and 36 h in the intervention group |
|
| ||||||
| Liu et al./2018 [ | Hip replacement surgery | (i) Control: usual care/ | EA, 3 days before surgery and 3 days after surgery, once daily, 30 min+30 min before surgery to the end of surgery | LI4, LR3 | MMSE, serum IL-1 | (i) Lower POCD incidence rate at postoperative day 4 in the intervention group |
|
| ||||||
| Sun et al./2018 [ | Gastrectomy for gastric carcinoma | (i) Control: usual care/ | EA, 20 min before surgery to the end of surgery | LI4, PC6, ST36, ST37 | MMSE, serum IL-6, TNF- | (i) Lower POCD incidence rate at postoperative day 3 in the EA group |
|
| ||||||
| Wang et al./2018 [ | Subtotal gastrectomy | (i) Control: usual care/ | EA, 15-20 min before surgery | LI4, PC6, ST36, ST37 | MMSE, MoCA, CD3+, CD4+, CD8+, CD4+/CD8+ ratio | (i) A trend of higher MMSE and MoCA scores at postoperative day 1 in the intervention group |
|
| ||||||
| Wang/2018 [ | Nonspecific type | (i) Control: usual care/ | EA, 30 min before surgery | DU20, PC6, ST36 | MMSE, serum IL-1 | (i) Higher MMSE scores at postoperative day 3 in the intervention group |
|
| ||||||
| Zeng and Wang/2018 [ | Lower abdomen surgery and lower limb surgery | (i) Control: usual care/ | EA, after surgery, daily for 30 days | BL23, DU20, GB20 | MMSE, acetylcholine and cholinesterase activity in cerebrospinal fluid | (i) Higher MMSE scores at postoperative days 1, 3, and 7 in the intervention group |
Abbreviations: MA: manual acupuncture; EA: electroacupuncture; TENS: transcutaneous electrical nerve stimulation; MMSE: Mini-Mental State Examination ((preoperative scores-postoperative scores) ≥ 2 indicates occurrence of POCD); FAQ: Functional Activities Questionnaire; MoCA: Montreal Cognitive Assessment; PONV: postoperative nausea and vomiting; QoR-40: 40-item quality of recovery score; QOR-9: quality of recovery-9; PQRS: postoperative quality recovery scale; IL-1β: interleukin-1β; IL-6: interleukin-6; IL-10: interleukin-10; TNF-α: tumor necrosis factor-α; S100β: S100 calcium-binding protein β; NSE: neuron-specific enolase; BDNF: brain-derived neurotrophic factor; 5-HT: 5-hydroxy tryptophan; β-EP: β-endorphin; BL23: Shenshu; DU14: Dazhui; DU17: Naohu; DU20: Baihui; DU21: Qianding; DU24: Shenting; EX-HN3: Yintang; GB4: Hanyan; GB6: Xuanli; GB7: Qubin; GB13: Benshen; GB19: Naokong; GB20: Fengchi; GB34: Yanglingquan; HT7: Shenmen; LI4: Hegu; LI10: Shousanli; LI11: Quchi; LR3: Taichong; LU2: Yunmen; LU7: Lieque; PC4: Ximen; PC6: Neiguan; SP6: Sanyinjiao; ST36: Zusanli; ST37: Shangjuxu.
Summary of animal studies examining the effects of acupuncture on POCD.
| Author/year | Type of surgery | Animals and study groups/group size | Acupuncture interventions | Acupoints | Results |
|---|---|---|---|---|---|
| Ye et al./2014 [ | Partial hepatectomy (PH) | (i) Male SD rats, 12 months old | EA, 30 min/day after surgery, for 1, 3, or 7 days | DU20, DU14 | (i) EA improved performance in MWM |
|
| |||||
| Yuan et al./2014 [ | Acute myocardial ischemia-reperfusion (AMIR) | (i) Male, SD rats, 18–24 months old | EA, immediately after reperfusion started, for 30 min | DU20, ST36 | (i) EA group showed a trend of improvement in working and reference memory in the 8-arm maze task |
|
| |||||
| Yin et al./2015 [ | Splenectomy (ST) | (i) Male SD rats, 20 months old | EA, 20 min before surgery | DU20, PC6, EX-HN3 | (i) EA improved performance in Y-maze |
|
| |||||
| Wang et al./2016 [ | Splenectomy (ST) | (i) Male SD rats, 18–20 months old | EA, 30 min/day, 5 days before surgery | DU20 | (i) EA improved performance in MWM |
|
| |||||
| Xie et al./2016 [ | No surgery | (i) Male and female SD rats, 20 months old | EA, during isoflurane anesthesia for 4 h | DU20 | (i) EA improved performance in MWM |
|
| |||||
| Chen et al./2017 [ | Trigeminal neuralgia (TN) model | (i) Male SD rats, 200–260 g | EA, 30 min each time, once every 2 days for 11 consecutive days | LI10, L111 | (i) EA improved performance in MWM |
|
| |||||
| Chen et al./2017 [ | Hepatic ischemia reperfusion (HIR) | (i) Male SD rats, 18–20 months old | EA, 30 min/day, 7 days before surgery | DU20, ST-36, PC6, LI11 | (i) EA improved performance in MWM |
|
| |||||
| Feng et al./2017 [ | Hepatolobectomy (HT) | (i) Male SD rats, 1 month old | EA, 30 min/day after surgery, for 1, 3, or 7 days | DU20, DU14 | (i) EA improved performance in Y-maze |
|
| |||||
| Feng et al./2017 [ | Partial hepatectomy (PH) | (i) Male SD rats, 21–23 months old | EA, 30 min/day after surgery, once every 2 days for 3 or 7 days | DU20, GV14 | (i) EA improved performance in MWM |
|
| |||||
| Liu et al./2017 [ | Partial hepatectomy (PH) | (i) Male SD rats, 18–20 months old | EA, 30 min preoperative to the end of surgery+30 min/day for 7 days after surgery | DU20, PC6, LI4 | (i) EA improved performance in MWM |
Abbreviations: PH: partial hepatectomy; AMIR: acute myocardial ischemia reperfusion; ST: splenectomy; TN: trigeminal neuralgia; HIR: hepatic ischemia reperfusion; HT: hepatic lobectomy; SD: Sprague Dawley; i.p.: intraperitoneal; EA: electroacupuncture; MWM: Morris water maze; IL-1β: interleukin-1β; IL-6: interleukin-6; TNF-α: tumor necrosis factor-α; MDA: malondialdehyde; SOD: superoxide dismutase; Iba-1: ionized calcium-binding adaptor molecule-1; α7-nAChR: α7-nicotinic acetylcholine receptors; p-GSK-3β: phosphorylated glycogen synthase kinase-3β; Aβ-24: amyloid β-protein-42; p-AMPK: phosphorylated adenosine 5′ monophosphate-activated protein kinase; NF-κB: nuclear factor κB; Ang II: angiotensin II; AT1R: angiotensin II type 1 receptor; Bcl-2: B-cell lymphoma/leukmia-2; Bax: Bcl-associated x protein; fEPSP: field excitatory postsynaptic potential; CHR: corticotropin-releasing hormone; ACTH: adrenocorticotropic hormone; LTP: long-term potentiation; HGMB1: high mobility group protein B1; TLR: toll-like receptor.